XiFin, Careviso collaborate on PA, RCM solutions
Careviso and XiFin are collaborating to enhance operational efficiencies for diagnostic laboratories by integrating Careviso’s PA services with XiFin’s RCM solutions.
Through technology integrations, process automation and service quality, this partnership aims to streamline laboratory workflows, optimize claim submissions and improve overall patient access to critical diagnostic services.
With more than 2 million prior authorizations completed since 2018, Careviso claims it has built a reputation for its analytics and direct connections to more than 4,000 payers.
[Read more: XiFin releases findings from 2025 Pharmacy Survey
Known for its AI-driven solutions that optimize operations, boost productivity and automate workflows, XiFin brings decades of expertise in revenue cycle management, providing laboratories, pharmacies, imaging centers and health systems with the solutions and insights needed to maximize reimbursements, process cleaner claims, reduce denials and accelerate revenue cycles across service areas.
By combining Careviso’s expertise in front-end benefits investigation and PAs with XiFin’s back-end RCM excellence, this relationship delivers an end-to-end solution for laboratories looking to enhance financial performance and operational efficiency, per the companies.
This collaboration is already in action, with a major publicly traded genetic testing company leveraging the combined expertise of Careviso and XiFin to support patients facing rare and inherited disorders. By ensuring timely and accurate access to prior authorizations and claims, this partnership enables healthcare service providers to focus on what matters most—improving patient outcomes.
[Read more: XiFin webinar focuses on how pharmacy can unlock insights to drive innovation, growth]
“Partnering in this alliance with XiFin allows careviso to expand our mission of simplifying access to healthcare,” said Andrew Mignatti, CEO of Careviso. “By combining our strengths in benefits investigation and prior authorization with XiFin’s leadership in revenue cycle management, we are setting a new standard for our clients.”
“Prior authorization continues to be a critical challenge across the entire healthcare system, impacting diagnostic laboratories, healthcare providers and patients alike,” said Lâle White, executive chair and CEO of XiFin. “By working with Careviso, we aim to help customers lower costs, accelerate approvals and reduce denials—ultimately improving patient access to necessary diagnostics and care.”